Articles

CBA Members

Intellectual
Property

CBA Intellectual Property Section

Articles are published by the Intellectual Property Section. Members interested in posting articles are encouraged to send them to the Section by email: CBAI_P@cba.org.

Today
Today

Case summary: Federal Court of Appeal denies a request for a cost variance

  • February 25, 2021
  • Hung Nguyen

This matter concerns an assessment of costs pursuant to 1) a Judgment of the Federal Court of Appeal (the “FCA”), wherein the Appellant’s appeal from an Order of the Federal Court was “dismissed with costs, including the costs of preparation of the appeal book”; and 2) an Order of the FCA, wherein the Respondent was awarded costs in relation to the Appellant’s motion.

Intellectual Property

Case summary: Federal Court of Appeal dismisses appeal of Federal Court judgment finding patent invalidity for anticipation and obviousness of three patents pertaining to inventions for all-terrain vehicles

  • February 25, 2021
  • Kelly McClellan

The Federal Court of Appeal dismissed an appeal of the Federal Court judgment, Camso Inc., v Soucy International Inc. et al., 2019 FC 255 (FC Reasons), dismissing an action involving three patents, 2,388,294 (the ‘294 Patent), 2,828,509 (the ‘509 Patent), and 2,822,562 (the ‘562 Patent), because it concluded the claims at issue in each patent were invalid for anticipation and obviousness (FCA Reasons 1, 2, 6).

Intellectual Property

Case summary: Filing of reply expert evidence

  • February 25, 2021
  • Ken Clark and Lawrence Veregin

This decision concerns a motion by the Plaintiffs to seek leave to file reply expert reports from its expert witnesses in a patent impeachment action. The reply expert reports include the experts’ responses to new issues and a rebuttal to the Defendant’s expert’s claim construction based on correspondence with the patent office during prosecution of the patent (s. 53.1(1) of the Patent Act).

Intellectual Property

Case summary: Lump sum costs for copyright infringement proceeding

  • February 25, 2021
  • Alan Macek

After a finding that the defendant had infringed the copyright in hundreds of photographs and other materials by reproducing them on several websites by way of summary judgment (see 2019 FC 1524) and an order awarding over $350,000 in statutory damages (see 2020 FC 794), the Court considered the appropriate costs award.

Intellectual Property

RAPAFLO formulation patent inventive, but not infringed; partial settlement of invalidity counterclaim was not effective

  • February 25, 2021
  • Will Boyer

In this decision under the PM(NOC) Regulations, Justice Crampton considered three separate issues and found that (1) Allergan’s formulation patent for RAPAFLO was not infringed by Sandoz’s proposed generic product; (2) file wrapper estoppel does not apply to an exclusive licensee; and (3) the formulation patent was not invalid for obviousness.

Intellectual Property